Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 2,820.40
-3.15 (-0.11%)
At close: Aug 21, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 465.09 billion as of August 21, 2026. Its market cap has increased by 45.24% in one year.
Market Cap
465.09B
Enterprise Value
434.34B
Revenue
67.25B
Ranking
n/a
PE Ratio
41.20
Stock Price
2,820.40
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 465.09B, an increase of 56.54%. That is a compound annual growth rate of 8.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 465.09B | 63.93% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.00T |
| Dr. Reddy's Laboratories | 978.76B |
| Abbott India | 557.70B |
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 285.49B |
| Granules India | 212.72B |
| Caplin Point Laboratories | 194.45B |